Xiangxue Pharmaceutical (300147) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.069x

Based on the latest financial reports, Xiangxue Pharmaceutical (300147) has a cash flow conversion efficiency ratio of 0.069x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥75.64 Million ≈ $11.07 Million USD) by net assets (CN¥1.10 Billion ≈ $160.78 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See how many days can Xiangxue Pharmaceutical fund operations to measure how many days the company can operate on defensive assets alone.

Xiangxue Pharmaceutical - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how Xiangxue Pharmaceutical's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Xiangxue Pharmaceutical Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Xiangxue Pharmaceutical ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Maoye Commercial Co Ltd SHG:600828	-0.003x
Berliner Effektengesellschaft AG F:BFV	N/A
Blue Jet Healthcare Limited NSE:BLUEJET	0.152x
Rukun Raharja Tbk JK:RAJA	0.041x
Lemon Tree Hotels Limited NSE:LEMONTREE	0.113x
Woori Technology Inc KQ:032820	-0.028x
Suqian Unitech Corp. Ltd. Cl A SHG:603065	N/A
Grupa Pracuj S.A. WAR:GPP	0.138x

Annual Cash Flow Conversion Efficiency for Xiangxue Pharmaceutical (2007–2025)

The table below shows the annual cash flow conversion efficiency of Xiangxue Pharmaceutical from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see 300147 stock market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	CN¥43.95 Million ≈ $6.43 Million	CN¥139.63 Million ≈ $20.43 Million	3.177x	+25054.40%
2024-12-31	CN¥1.44 Billion ≈ $210.55 Million	CN¥18.17 Million ≈ $2.66 Million	0.013x	-88.91%
2023-12-31	CN¥2.31 Billion ≈ $338.50 Million	CN¥263.44 Million ≈ $38.55 Million	0.114x	+41.15%
2022-12-31	CN¥2.82 Billion ≈ $412.39 Million	CN¥227.38 Million ≈ $33.27 Million	0.081x	+17.71%
2021-12-31	CN¥3.76 Billion ≈ $549.88 Million	CN¥257.56 Million ≈ $37.69 Million	0.069x	+13.35%
2020-12-31	CN¥4.25 Billion ≈ $622.35 Million	CN¥257.18 Million ≈ $37.63 Million	0.060x	+199.49%
2019-12-31	CN¥4.11 Billion ≈ $601.66 Million	CN¥83.02 Million ≈ $12.15 Million	0.020x	-11.21%
2018-12-31	CN¥4.01 Billion ≈ $587.12 Million	CN¥91.24 Million ≈ $13.35 Million	0.023x	-19.37%
2017-12-31	CN¥3.88 Billion ≈ $568.31 Million	CN¥109.53 Million ≈ $16.03 Million	0.028x	-47.65%
2016-12-31	CN¥3.68 Billion ≈ $539.14 Million	CN¥198.48 Million ≈ $29.04 Million	0.054x	+19.47%
2015-12-31	CN¥3.55 Billion ≈ $518.89 Million	CN¥159.89 Million ≈ $23.40 Million	0.045x	-49.04%
2014-12-31	CN¥1.87 Billion ≈ $273.82 Million	CN¥165.58 Million ≈ $24.23 Million	0.088x	-53.92%
2013-12-31	CN¥1.71 Billion ≈ $250.23 Million	CN¥328.37 Million ≈ $48.05 Million	0.192x	+148.14%
2012-12-31	CN¥1.54 Billion ≈ $224.85 Million	CN¥118.91 Million ≈ $17.40 Million	0.077x	+271.56%
2011-12-31	CN¥1.42 Billion ≈ $207.64 Million	CN¥29.55 Million ≈ $4.32 Million	0.021x	-37.21%
2010-12-31	CN¥1.37 Billion ≈ $200.56 Million	CN¥45.47 Million ≈ $6.65 Million	0.033x	-75.75%
2009-12-31	CN¥337.62 Million ≈ $49.41 Million	CN¥46.19 Million ≈ $6.76 Million	0.137x	-51.75%
2008-12-31	CN¥196.54 Million ≈ $28.76 Million	CN¥55.72 Million ≈ $8.15 Million	0.284x	-60.67%
2007-12-31	CN¥191.45 Million ≈ $28.02 Million	CN¥138.02 Million ≈ $20.20 Million	0.721x	--

About Xiangxue Pharmaceutical

SHE:300147 China Biotechnology

Market Cap

$957.98 Million

CN¥6.55 Billion CNY

Market Cap Rank

#9248 Global

#2364 in China

Share Price

CN¥9.90

Change (1 day)

+9.03%

52-Week Range

CN¥7.58 - CN¥11.74

All Time High

CN¥25.81